{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:41:20Z","timestamp":1761871280495,"version":"build-2065373602"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.clml.2018.10.004","type":"journal-article","created":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T21:13:13Z","timestamp":1539378793000},"page":"e1-e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Histiocytic Sarcoma Associated With Follicular Lymphoma: Evidence for Dramatic Response With Rituximab and Bendamustine Alone and a Review of the Literature"],"prefix":"10.1016","volume":"19","author":[{"given":"Michael","family":"Farris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan T.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0647-3963","authenticated-orcid":false,"given":"Zanetta","family":"Lamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Soike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua R.","family":"Menke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Ohgami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Winkfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2018.10.004_bib1","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","article-title":"Revised classification of histiocytoses and neoplasms of the macrophage\u2013dendritic cell lineages","volume":"127","author":"Emile","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.10.004_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2017-10-812495","article-title":"Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes","volume":"131","author":"Kommalapati","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.10.004_bib3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1470-2045(04)01428-7","article-title":"Histiocytic sarcoma after acute lymphoblastic leukaemia: a common clonal origin","volume":"5","author":"Feldman","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2018.10.004_bib4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1470-2045(05)70211-4","article-title":"Clonal relationship between precursor T-lymphoblastic leukaemia\/lymphoma and Langerhans-cell histiocytosis","volume":"6","author":"Feldman","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2018.10.004_bib5","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/modpathol.2011.102","article-title":"Clonally related histiocytic\/dendritic cell sarcoma and chronic lymphocytic leukemia\/small lymphocytic lymphoma: a study of seven cases","volume":"24","author":"Shao","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clml.2018.10.004_bib6","first-page":"386","article-title":"Langerhans cell sarcoma arising from chronic lymphocytic lymphoma\/small lymphocytic leukemia: lineage analysis and BRAF V600E mutation study","volume":"5","author":"Chen","year":"2013","journal-title":"N\u00a0Am J Med Sci"},{"key":"10.1016\/j.clml.2018.10.004_bib7","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1200\/JCO.2013.49.0078","article-title":"BRAF(V600E) mutation in a histiocytic sarcoma arising from hairy cell leukemia","volume":"32","author":"Michonneau","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2018.10.004_bib8","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1182\/blood-2016-08-735795","article-title":"Histiocytic sarcoma: secondary neoplasm or \u201ctransdifferentiation\u201d in the setting of B-acute lymphoblastic leukemia","volume":"128","author":"Thakral","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.10.004_bib9","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/modpathol.3800346","article-title":"Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163","volume":"18","author":"Vos","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clml.2018.10.004_bib10","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/01.pas.0000131541.95394.23","article-title":"Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy","volume":"28","author":"Hornick","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2018.10.004_bib11","doi-asserted-by":"crossref","first-page":"e427","DOI":"10.1016\/j.clml.2018.07.286","article-title":"Clinicopathologic features and clinical outcome differences in de novo versus secondary histiocytic sarcomas: a multi-institutional experience and review of the literature","volume":"18","author":"Broadwater","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2018.10.004_bib12","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1182\/blood-2007-11-124792","article-title":"Clonally related follicular lymphomas and histiocytic\/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone","volume":"111","author":"Feldman","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.10.004_bib13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.5858\/arpa.2012-0104-RS","article-title":"Histiocytic\/dendritic cell transformation of B-cell neoplasms: pathologic evidence of lineage conversion in differentiated hematolymphoid malignancies","volume":"137","author":"Stoecker","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.clml.2018.10.004_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-0560.1993.tb00226.x","article-title":"Cutaneous histiocytic malignancy. Immunohistochemical re-examination of cases previously diagnosed as cutaneous \u201chistiocytic lymphoma\u201d and \u201cmalignant histiocytosis","volume":"20","author":"Arai","year":"1993","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.clml.2018.10.004_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2559.2002.01418.x","article-title":"Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases","volume":"41","author":"Pileri","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.clml.2018.10.004_bib16","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.10.004_bib17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1309\/M95G-7DQ2-TLQL-7Q11","article-title":"Interdigitating dendritic cell sarcoma. A report of four cases and review of the literature","volume":"115","author":"Gaertner","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2018.10.004_bib18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s12185-014-1630-y","article-title":"Successful treatment of histiocytic sarcoma with induction chemotherapy consisting of dose-escalated CHOP plus etoposide and upfront consolidation auto-transplantation","volume":"100","author":"Tsujimura","year":"2014","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clml.2018.10.004_bib19","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1200\/JCO.2010.32.6603","article-title":"Autologous hematopoietic stem-cell transplantation in combination with thalidomide as treatment for histiocytic sarcoma: a case report and review of the literature","volume":"29","author":"Gergis","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2018.10.004_bib20","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.3747\/co.19.964","article-title":"Long-term remission after autologous stem-cell transplantation for relapsed histiocytic sarcoma","volume":"19","author":"Abu-Sanad","year":"2012","journal-title":"Curr Oncol"},{"key":"10.1016\/j.clml.2018.10.004_bib21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/1096-8644(200011)113:3<389::AID-AJPA9>3.0.CO;2-I","article-title":"Bone mineral density, osteopenia, and osteoporosis in the rhesus macaques of Cayo Santiago","volume":"113","author":"Cerroni","year":"2000","journal-title":"Am J Phys Anthropol"},{"key":"10.1016\/j.clml.2018.10.004_bib22","first-page":"728260","article-title":"Successful treatment of multifocal histiocytic sarcoma occurring after renal transplantation with cladribine, high-dose cytarabine, G-CSF, and mitoxantrone (CLAG-M) followed by allogeneic hematopoietic stem cell transplantation","volume":"2015","author":"Tomlin","year":"2015","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.clml.2018.10.004_bib23","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/apm.12576","article-title":"Long-term treatment with the oncolytic ECHO-7 virus Rigvir of a melanoma stage IV M1c patient, a small cell lung cancer stage IIIA patient, and a histiocytic sarcoma stage IV patient\u2014three case reports","volume":"124","author":"Alberts","year":"2016","journal-title":"APMIS"},{"key":"10.1016\/j.clml.2018.10.004_bib24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12185-017-2202-8","article-title":"Successful treatment of histiocytic sarcoma with cladribine and high-dose cytosine arabinoside in a child","volume":"106","author":"Iwabuchi","year":"2017","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clml.2018.10.004_bib25","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1542\/peds.2005-0026","article-title":"Histiocytic sarcoma in a 3-year-old male: a case report","volume":"116","author":"Buonocore","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.clml.2018.10.004_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3171\/2013.6.PEDS12533","article-title":"Primary histiocytic sarcoma of the brain mimicking cerebral abscess","volume":"12","author":"Almefty","year":"2013","journal-title":"J\u00a0Neurosurg Pediatr"},{"key":"10.1016\/j.clml.2018.10.004_bib27","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1590\/abd1806-4841.20132070","article-title":"Case report of cutaneous histiocytic sarcoma: diagnostic and therapeutic dilemmas","volume":"88","author":"Trevisan","year":"2013","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clml.2018.10.004_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10014-014-0191-3","article-title":"Histiocytic sarcoma of the cavernous sinus: case report and literature review","volume":"32","author":"Chen","year":"2015","journal-title":"Brain Tumor Pathol"},{"key":"10.1016\/j.clml.2018.10.004_bib29","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1017\/S1460396914000491","article-title":"Radiotherapy for histiocytic sarcoma: a case report","volume":"14","author":"Bourgeois","year":"2015","journal-title":"J\u00a0Radiother Pract"},{"key":"10.1016\/j.clml.2018.10.004_bib30","first-page":"16808","article-title":"Complete response after chemotherapy and radiotherapy of a tonsillar histiocytic sarcoma with regional lymph node involvement: a case report and review of the literature","volume":"8","author":"Chen","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.clml.2018.10.004_bib31","doi-asserted-by":"crossref","first-page":"300","DOI":"10.20517\/2394-5079.2016.10","article-title":"Aggressive primary hepatic histiocytic sarcoma: case report and literature review","volume":"2","author":"Yang","year":"2016","journal-title":"Hepatoma Res"},{"key":"10.1016\/j.clml.2018.10.004_bib32","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMc1511490","article-title":"Trametinib in histiocytic sarcoma with an activating MAP2K1 (MEK1) mutation","volume":"378","author":"Gounder","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2018.10.004_bib33","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/00000478-199611000-00013","article-title":"True histiocytic lymphoma of the stomach associated with low-grade B-cell mucosa-associated lymphoid tissue (MALT)-type lymphoma","volume":"20","author":"Alvaro","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2018.10.004_bib34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13000-015-0350-9","article-title":"Histiocytic sarcoma combined with acute monocytic leukemia: a case report","volume":"10","author":"Zhao","year":"2015","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.clml.2018.10.004_bib35","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1200\/JCO.2011.38.8553","article-title":"Histiocytic sarcoma arising from clonally related mantle cell lymphoma","volume":"30","author":"Hure","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2018.10.004_bib36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/pbc.22810","article-title":"Pediatric histiocytic sarcoma clonally related to precursor B-cell acute lymphoblastic leukemia with homozygous deletion of CDKN2A encoding p16INK4A","volume":"56","author":"Kumar","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clml.2018.10.004_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ejh.12755","article-title":"Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment","volume":"97","author":"Ansari","year":"2016","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2018.10.004_bib38","first-page":"135","article-title":"Transformation of B cell lymphoma to histiocytic sarcoma: somatic mutations of PAX-5 gene with loss of expression cannot explain transdifferentiation","volume":"2","author":"Bassarova","year":"2009","journal-title":"J\u00a0Hematop"},{"key":"10.1016\/j.clml.2018.10.004_bib39","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1600-0560.2011.01769.x","article-title":"Histiocytic sarcoma transdifferentiated from follicular lymphoma presenting as a cutaneous tumor","volume":"38","author":"Zeng","year":"2011","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.clml.2018.10.004_bib40","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1038\/leu.2014.167","article-title":"Follicular lymphoma transformation into histiocytic sarcoma: indications for a common neoplastic progenitor","volume":"28","author":"Brunner","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2018.10.004_bib41","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1309\/NNTGETJNJY2UB3Y1","article-title":"Histiocytic proliferations in childhood","volume":"122","author":"Onciu","year":"2004","journal-title":"Pathol Patterns Rev"},{"key":"10.1016\/j.clml.2018.10.004_bib42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/106689690501300314","article-title":"Mediastinal germ cell tumor associated with histiocytic sarcoma of spleen: case report of an unusual association","volume":"13","author":"Song","year":"2005","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.clml.2018.10.004_bib43","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3109\/10428191003699845","article-title":"Histiocytic sarcoma arising in indolent small B-cell lymphoma: report of two cases with molecular\/genetic evidence suggestive of a \u201ctransdifferentiation\u201d during the clonal evolution","volume":"51","author":"Wang","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2018.10.004_bib44","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3109\/10428194.2011.565840","article-title":"A case of resistant pediatric histiocytic sarcoma successfully treated with chemo-radiotherapy and autologous peripheral blood stem cell transplant","volume":"52","author":"Mainardi","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2018.10.004_bib45","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1002\/cncr.26712","article-title":"Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab","volume":"118","author":"Shukla","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2018.10.004_bib47","first-page":"66","article-title":"Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma","volume":"26","author":"Grillo-L\u00f3pez","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clml.2018.10.004_bib48","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1212\/WNL.0000000000000880","article-title":"Dramatic response of a BRAF V600E\u2013mutated primary CNS histiocytic sarcoma to vemurafenib","volume":"83","author":"Idbaih","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.clml.2018.10.004_bib49","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2159-8290.CD-15-0913","article-title":"Diverse and targetable kinase alterations drive histiocytic neoplasms","volume":"6","author":"Diamond","year":"2016","journal-title":"Cancer Discov"},{"key":"10.1016\/j.clml.2018.10.004_bib50","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13256-017-1253-z","article-title":"BRAF V600E expression in histiocytic sarcoma associated with splenic marginal zone lymphoma: a case report","volume":"11","author":"Vaughn","year":"2017","journal-title":"J\u00a0Med Case Rep"},{"key":"10.1016\/j.clml.2018.10.004_bib51","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/his.12416","article-title":"Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms","volume":"65","author":"Go","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.clml.2018.10.004_bib52","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.18632\/oncotarget.2061","article-title":"Potential clinical implications of BRAF mutations in histiocytic proliferations","volume":"5","author":"Bubolz","year":"2014","journal-title":"Oncotarget"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265018313363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265018313363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:32:35Z","timestamp":1761870755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265018313363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S2152265018313363"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2018.10.004","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histiocytic Sarcoma Associated With Follicular Lymphoma: Evidence for Dramatic Response With Rituximab and Bendamustine Alone and a Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2018.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}